Skip to main content

Definium Therapeutics, Inc.

DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001813814

In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Definium Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of DFTX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1042135+33
Shares4.88M734.8M+29.9M (+612.9%)
Value$17.9M$26$327.2M+$309.4M (+1,731.0%)

2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held Definium Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to DFTX in Q1 2024
InstitutionSharesValue% of portfolio
Deep Track Capital, LP6,666,667$62.7M1.80%
Commodore Capital LP5,833,333$54.8M3.67%
Driehaus Capital Management LLC2,547,545$23.9M0.24%
Octagon Capital Advisors LP2,153,000$20.2M2.46%
Great Point Partners LLC2,000,000$18.8M2.93%
Marshall Wace, LLP1,998,544$18.8M0.03%
Blackstone Group Inc.1,249,875$11.7M0.05%
Ally Bridge Group (NY) LLC1,001,452$9.41M5.23%
Woodline Partners LP1,000,579$9.41M0.09%
Janus Henderson Group PLC955,678$8.96M0.00%
AWM Investment Company, Inc.833,000$7.83M1.03%
Soleus Capital Management, L.P.750,237$7.05M0.62%
Tri Locum Partners LP379,596$3.57M1.24%
Tang Capital Management LLC300,000$2.82M0.29%
HRT Financial LP207,253$1.95M0.01%
D. E. Shaw & Co., Inc.183,029$1.72M0.00%
Toroso Investments, LLC180,600$1.70M0.03%
Man Group plc112,177$1.05M0.00%
Squarepoint Ops LLC57,650$541.9K0.00%
Wellington Management Group LLP55,065$517.6K0.00%
Laurion Capital Management LP30,426$286.0K0.01%
Caxton Corp29,065$273.2K1.56%
Cubist Systematic Strategies, LLC28,618$269.0K0.00%
Virtu Financial LLC25,440$239.0K0.02%
GTS Securities LLC24,921$234.3K0.01%
Two Sigma Advisers, LP21,917$206.0K0.00%
Sequoia Financial Advisors, LLC17,912$168.4K0.00%
LMR Partners LLP16,374$153.9K0.00%
Chiron Investment Management, LLC15,932$149.8K0.06%
PEAK6 Investments LLC15,454$145.3K0.01%
Mercer Global Advisors Inc14,928$140.0K0.00%
Raymond James Financial Services Advisors, Inc.13,762$129.4K0.00%
Polymer Capital Management (HK) LTD11,926$112.1K0.03%
Blair William & Co11,341$106.6K0.00%
Brevan Howard Capital Management LP10,649$100.1K0.01%
Thrivent Financial for Lutherans10,027$94.0K0.00%
North Star Investment Management Corp.2,150$20.2K0.00%
Symmetry Peak Management LLC800$7.52K0.15%
NBC Securities, Inc.600$5.00K0.00%
CIBC Private Wealth Group, LLC434$4.13K0.00%
Federated Hermes, Inc.247$2.32K0.00%
Continuum Advisory, LLC20$1820.00%
CoreCap Advisors, LLC15$1410.00%
Macquarie Group Ltd3,779$360.00%
Sofos Investments, Inc.2$190.00%
SageView Advisory Group, LLC2,648––

Sold out (13)

Institutions that held Definium Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Not filed for Q1 2024 yet (2)

Institutions that held Definium Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DFTX in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Strategic Investment Solutions, Inc.6$22
Coppell Advisory Solutions LLC1$4